Ameliorating effect of TI-1-162, a hydroxyindenone derivative, against TNBS-induced rat colitis is mediated through suppression of RIP/ASK-1/MAPK signaling.

MLA

Gurung, Pallavi, et al. “Ameliorating Effect of TI-1-162, a Hydroxyindenone Derivative, against TNBS-Induced Rat Colitis Is Mediated through Suppression of RIP/ASK-1/MAPK Signaling.” European Journal of Pharmacology, vol. 827, May 2018, pp. 94–102. EBSCOhost, https://doi.org/10.1016/j.ejphar.2018.03.027.

APA

Gurung, P., Banskota, S., Katila, N., Gautam, J., Kadayat, T. M., Choi, D.-Y., Lee, E. S., Jeong, T. C., & Kim, J.-A. (2018). Ameliorating effect of TI-1-162, a hydroxyindenone derivative, against TNBS-induced rat colitis is mediated through suppression of RIP/ASK-1/MAPK signaling. European Journal of Pharmacology, 827, 94–102. https://doi.org/10.1016/j.ejphar.2018.03.027

Chicago

Gurung, Pallavi, Suhrid Banskota, Nikita Katila, Jaya Gautam, Tara Man Kadayat, Dong-Young Choi, Eung Seok Lee, Tae Cheon Jeong, and Jung-Ae Kim. 2018. “Ameliorating Effect of TI-1-162, a Hydroxyindenone Derivative, against TNBS-Induced Rat Colitis Is Mediated through Suppression of RIP/ASK-1/MAPK Signaling.” European Journal of Pharmacology 827 (May): 94–102. doi:10.1016/j.ejphar.2018.03.027.